Among the various potential mechanisms that have been discussed after the publication of PARADIGM-HF, it seems unlikely, based on the previous clinical comparison between ACE inhibitors and ARBs that the benefits of LCZ696 are due to the ARB component of the ARNI by itself. Here, ACE is linked to hydrops fetalis.